A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease Vered Abitbol, Karine Briot, Christian Roux, Carine Roy, Philippe Seksik, Antoine Charachon, Yoram Bouhnik, Benoit Coffin, Matthieu Allez, Dominique Lamarque, Stanislas Chaussade Clinical Gastroenterology and Hepatology Volume 5, Issue 10, Pages 1184-1189 (October 2007) DOI: 10.1016/j.cgh.2007.05.016 Copyright © 2007 AGA Institute Terms and Conditions
Figure 1 Trial profile. Clinical Gastroenterology and Hepatology 2007 5, 1184-1189DOI: (10.1016/j.cgh.2007.05.016) Copyright © 2007 AGA Institute Terms and Conditions
Figure 2 BMD changes during 1 year in placebo and clodronate groups. Clinical Gastroenterology and Hepatology 2007 5, 1184-1189DOI: (10.1016/j.cgh.2007.05.016) Copyright © 2007 AGA Institute Terms and Conditions